Implantica AG announced private placement of 4,900,000 class A shares at a price of SEK 122.2 per share for gross proceeds of SEK 598,780,000 on April 15, 2021. The transaction will include participation from a number of new and existing institutional investors, including DNCA Finance, Handelsbanken Asset Management, Swedbank Robur Fonder AB, Teknik Innovation Norden Fonder AB, and The Invus Group, LLC. The investors will acquire approximately 7.1% stake in the company.

The transaction will be conducted through an accelerated book building procedure. The transaction has been approved by the board of directors of the company and is subject to approval of shareholders in annual general meeting to be held on April 16, 2021. The transaction was over-subscribed.

The total number of shares will increase by 4,900,000 shares from 109,461,537 to 114,361,537, whereof 58,111,537 are class A shares represented by Swedish depository receipts, and 56,250,000 are class B shares. The shares are under lock-up until September 16, 2021.